Grant funds conference on reducing food waste

A $280,000 grant form the Rockefeller Foundation will fund a Cornell-led workshop in New York City for business leaders to explore strategies to reduce food waste and loss through new products and services.

Weill Cornell lab helps translate ideas into innovations

The Dean's Entrepreneurship Lab provides resources and education opportunities to students and faculty who have ideas with commercial potential that they want to translate from the lab to the patient.

Two Sigma to be first tenant at The Bridge at Cornell Tech

Forest City Ratner Cos. announced Jan. 23 that Two Sigma Investments, a tech and investment firm, is the first company to be selected to locate at The Bridge at Cornell Tech.

New technique improves blood flow to damaged tissues

A gene essential for making blood vessels in embryos can successfully transform amniotic cells into therapeutic blood vessel cells, according to new research from Weill Cornell Medicine.

Brain cells mobilize sugar in response to increased activity

New research from Weill Cornell Medicine provides insights into why the brain is so reliant on sugar to function.

Dr. Augustine M.K. Choi named dean of Weill Cornell Medicine

Choi unanimously was elected the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and Cornell's provost for medical affairs Jan. 17.

As routine screenings drop, prostate cancer on rise in older men

The incidence of metastatic prostate cancer in older men is rising after reaching an all-time low in 2011. The findings suggest a correlation between the increase and a change in prostate cancer screening guidelines recommending against routine PSA testing.

Research reveals codes that control protein expression

Scientists from Weill Cornell Medicine discovered an internal code in cellular molecules, called messenger RNA, predetermines how much protein they will produce.

New model could benefit liver cancer transplant patients

A simple blood test may better predict which patients diagnosed with liver cancer will experience disease reoccurrence, according to new research from Weill Cornell Medicine scientists.